Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MSD

Latest From MSD

AstraZeneca/Daiichi Sankyo’s Enhertu To Get Lung Cancer Label For EU

The European Medicines Agency has recommended new uses for 11 approved medicines, including an antibody drug conjugate for treating advanced non-small cell lung cancer.

Europe Approvals

Pharma Cash Keeps Flowing Into Ireland

MSD and Astellas have joined Lilly, Takeda and AstraZeneca in making major investments in Ireland this year.

Ireland Deals

Roche’s Seven-Minute Tecentriq Jab Wins First Ever Regulatory Approval

The National Health Service in England says it will be the first health system in the world to roll out a subcutaneously administered formulation of Tecentriq, after the UK MHRA became the first drug regulator to approve the product.

Approvals United Kingdom

Astex Bags Another Cancer Deal With MSD, This Time For ‘Undruggable’ p53 Target

The UK-based biotech will license its Pyramid platform to MSD to develop anticancer compounds targeting p53, a key transcription factor dubbed the ‘guardian of the genome’ that has proven highly complex and challenging to drug.

Deals Companies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Merck Sharpe & Dome
UsernamePublicRestriction

Register